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Predicting the Long-Term Outcome after Subacute Stroke within 
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Background and Purpose: The National Institutes of Health Stroke Scale (NIHSS) score is known to be 
effective in predicting the likelihood of recovery after stroke. However, the baseline NIHSS score predicts long-term 
outcomes rather crudely because early changes in stroke scores may influence the stroke outcomes. Therefore, a 
precise prognostic algorithm or a cutoff point for predicting long-term outcomes based on data from serial NIHSS 
scores is needed.
Methods: We serially assessed 437 patients with acute symptomatic ischemic stroke within the middle cerebral 
artery territory who presented with nonlacunar stroke and were followed-up for at least 6 months after symptom 
onset. The NIHSS score was serially checked at 0, 1, 3, 7, and 14 days after admission. In all patients, the Barthel 
index (BI) and the modified Rankin Scale (mRS) score were checked, with a poor outcome defined as any of the 
following endpoints: death, modified mRS score of >3, or BI of <60.
Results: A marked neurological improvement or worsening (i.e., a change in the NIHSS score of at least 4) was 
seen in 13.5% or 5.5% of the patients, respectively, during the first 7 days after admission. About 25% of the 437 
patients had poor long-term outcomes. Analysis of receiver operating characteristic curves showed that the NIHSS 
score at day 7 after admission was better for predicting poor long-term outcomes than was the baseline score (P= 
0.003). In addition, we analyzed the cutoff point of the 7th-day NIHSS score for predicting a poor outcome at 6 
months after symptom onset. An NIHSS score of at least 6 at day 7 after admission predicted poor long-term 
outcomes with a sensitivity of 84% [95% confidence interval (CI), 76-90%], a specificity of 92% (95% CI, 88-94%), 
and positive and negative predictive values of 77% and 95%, respectively. A logistic regression analysis revealed 
that age, diffusion-weighted imaging lesion volume, stroke history, and 7th-day NIHSS score were independently 
associated with poor outcome. However, no score used in addition to the 7th-day NIHSS score improved the 
prediction of a poor outcome.
Conclusions: An NIHSS score of at least 6 on day 7 after admission accurately forecasts a poor long-term 
outcome after stroke. Our data may be helpful in predicting the long-term prognosis as well as in making decisions 
regarding novel therapeutic applications in subacute-stroke trials.
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INTRODUCTION
Forecasts of recovery from stroke have focused on the 
scores of neurological scales at admission or on the 
selection of patients to be treated with recombinant Bang OY, et al. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory  
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Figure 1. Patient selection.
tissue plasminogen activator.
1-6 Unfortunately, no models 
for subacute-stroke trials have been described. Accurate 
prognostic models for patients with subacute stroke 
would have several important uses, such as guiding 
patient management
7,8 (e.g., patients with a good 
prognosis could be spared potentially risky treatments 
such as stem cell therapy
9,10), allowing more reliable 
information to be given to patients and their relatives,
8 
and improving the planning of patient rehabilitation and 
discharge.
11
The recovery profile of stroke can vary nonlinearly 
with the severity, with the course of improvement being 
greater at the lower end of the deficit scale. When this 
is the case, many patients enrolled with low predictive 
scores will improve regardless of treatment, reducing the 
likelihood of a real protective effect of treatment being 
detected. Conversely, some patients worsen relative to 
the initial severity of their stroke, resulting in further 
neuronal injury and less favorable outcomes.
2 False- 
positive and false-negative predictions of long-term 
outcome can be detrimental to patients, with the possi-
bility of the needless provision of hazardous treatment or 
the incorrect denial of effective treatment, respectively. 
Therefore, understanding the clinical course after stroke 
and the time point for enrollment in subacute-stroke 
trials may help with the design of a prestudy randomi-
zation schedule and power analysis.
The National Institutes of Health Stroke Scale 
(NIHSS) is an attractive candidate predictor because it is 
widely used, is easily learned, and can be performed 
rapidly on admission. Moreover, the NIHSS score is 
known to predict the likelihood of patient recovery after 
stroke. However, the baseline NIHSS score predicts long- 
term outcomes rather crudely, and the fate of patients 
with intermediate scores is unclear.
12 Therefore, a 
precise prognostic algorithm or a cutoff point to predict 
poor long-term outcomes based on data from serial 
NIHSS scores is needed.
In this study, we evaluated the cutoff point - in terms 
of time point and severity as measured by serial NIHSS 
scores - for predicting long-term outcomes. In addition, 
we investigated a prognostic model for long-term 
outcomes.
MATERIALS AND METHODS
1. Patient selection
From October 2000 to October 2004, we prospectively 
studied consecutive patients with acute symptomatic 
middle cerebral artery (MCA) territory infarcts who 
were admitted to the Department of Neurology at Ajou 
University Hospital, Korea. All patients had suffered 
from focal symptoms and had been observed within 72 
hours of symptom onset, showed relevant lesions within 
the MCA distribution territory on magnetic resonance 
diffusion-weighted imaging (DWI), had undergone 
complete workups, including vascular and cardiologic 
workups, and were followed for more than 6 months 
(Fig. 1). All of the patients provided their informed 
consent to participate in the study. We excluded patients 
who presented with lacunar stroke or stroke recurrence 
within 6 months; those who were treated for thrombolysis, 
hypothermia, or craniectomy; and those who were 
discharged against medical advice, absconded from the 
hospital, or died during the acute phase of stroke, since 
such cases are not typical of the disposition after stroke 
care.
Of 748 stroke patients who were admitted during the 
study period, the above criteria lead to 437 patients 
being were included in this study (Fig. 1): 263 men 
(60%) and 174 women (40%), aged 62.1±12.8 (mean± Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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SD) years (range, 32-91 years).
2. Workup
Patients were evaluated according to a protocol that 
included demographic data, medical history, vascular 
risk factors, and stroke scale scores [NIHSS score, 
Barthel index (BI), and the modified Rankin Scale 
(mRS) score], as in our previous study.
13 Both T2- 
weighted imaging and DWI were performed using a 
clinical 1.5-T magnetic resonance imaging system, and 
all patients underwent diagnostic testing, which included 
digital-subtraction or magnetic resonance angiography, 
electrocardiography, and routine blood tests. Echocardio-
graphy was performed in 381 patients (87%). The degree 
of stenosis was measured as in our previous study,
13 
with occlusion defined as >50% stenosis or occlusion of 
the large intracranial vessels and internal carotid artery. 
We also measured the volumes of the DWI lesion(s) in 
429 patients (98.2%). The DWI lesion volumes were 
calculated by multiplying the measured area per slice by 
the section thickness (conditions: repetition time, 10,000 
ms; echo time, 104 ms; slice thickness, 7 mm; no gap). 
The NIHSS score was serially checked at baseline and 
at 1, 3, 7, and 14 days after admission. The hospital 
course was determined on day 7 after admission, and 
marked deterioration was defined as an increase in the 
NIHSS score of at least 4 during the first 7 days of 
hospitalization, as used previously.
14
Two endpoints were evaluated at 6 months after 
ischemic stroke: poor outcome and excellent outcome. 
The BI and mRS score are the outcome measures that 
have been used most frequently in studies focusing on 
stroke-related disability and recovery of motor function 
after stroke. Both the mRS score and BI have been 
shown to be reliable and valid for use in stroke.
15 To 
define the outcome for stroke patients, we used a global 
endpoint that combined the mRS score and BI for the 
following reasons. First, this combination has been 
reported to be more powerful than the BI endpoints, and 
it reduces the required sample size.
16 Second, the mRS 
score may be less reproducible owing to its relative lack 
of structure,
17 whereas the BI has a U-shaped distri-
bution in which patient outcomes cluster at the extremes. 
The BI and mRS score were serially checked for more 
than 6 months (up to 1 year). We defined a poor 
outcome as any of the following endpoints: death, mRS 
score of >3, or BI of <60.
18 An excellent outcome was 
defined as reaching both of the following endpoints: 
mRS score of 0 or 1, and BI of ≥95.
3. Statistical analysis
Receiver operating characteristic (ROC) curves were 
used to assess the usefulness of the individual NIHSS 
scores in predicting a poor or good outcome. We 
assessed discrimination by calculating the area under the 
ROC curve of sensitivity versus 1 minus the specificity. 
An area of 1 implies a test with perfect sensitivity and 
specificity, while an area of 0.5 implies that the model's 
predictions are no better than chance. The best model for 
each outcome in each test cohort was defined as the 
model with the largest ROC curve area or, if there were 
no statistically significant differences in the areas, the 
model with the most practical curve. The sensitivity, 
specificity, and positive and negative predictive values 
of the clinical predictions - along with their associated 
95% confidence intervals (CIs) - were calculated and 
plotted on the ROC curve to validate the individual 
scores in predicting poor and good outcomes at 6 
months.
Stepwise logistic regression was used to assess which 
subset of variables best predicted a good or poor 
outcome as defined above. In addition to the NIHSS 
scores, several baseline variables were collected at 
enrollment: patient age and sex; presence of conven-
tional vascular risk factors (hypertension, diabetes, 
hyperlipidemia, and atrial fibrillation); history of stroke 
or coronary heart disease; serum levels of inflammatory 
markers (C-reactive protein and fibrinogen); presence of 
metabolic syndrome; stroke subtypes (artherosclerotic, 
cardioembolic, cryptogenic, other determined etiology); 
vascular status (stenosis of ≥50% or occlusion); DWI 
lesion volume; and presence of aggravating factors 
during the first 3 days of admission, such as admission 
hyperglycemia (blood sugar >300 mg/dl), hyperthermia 
(body temperature >38.5℃), hypoxia, or hypotension 
(systolic blood pressure <100 mmHg or sudden drop of Bang OY, et al. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory  
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Predictor variable Characteristic
Age, year 62.1±12.8
Sex
Male 
Female
263 (60%)
174 (40%)
Risk factors
Hypertension
Diabetes
Atrial fibrillation
Hyperlipidemia
Stroke history
CAOD history
Metabolic syndrome
C-reactive protein
Fibrinogen
238 (54.7%)
116 (26.7%)
 73 (16.7%)
 80 (18.4%)
103 (23.7%)
 46 (10.5%)
 48 (32.4%)
 0.64±1.81
373.0±125.7
Stroke subtype
Atherosclerotic
Cardioembolic 
Cryptogenic 
Other determined etiology
253 (57.9%)
 97 (22.2%)
 67 (15.3%)
 20 (4.6%)
DWI lesion volume, ml 30.56±55.18
Vascular status
Stenosis (≥50%)
Occlusion
178 (41.5%)
143 (32.7%)
Systemic aggravating factors
Hyperpyremia
Hyperglycemia 
Hypoxia or hypotension
 24 (5.5%)
  7  ( 1 . 6 % )
 28 (6.4%)
Table 1. Predictor-variable characteristics >30 mmHg). Most of the parameters were dichotomized 
(normal versus abnormal) in order to minimize the 
number of variables, improve the reliability of data 
collection, and simplify the clinical procedures. Those 
variables that were significant at the P<0.2 level were 
entered into the initial multivariate model. When the 
most parsimonious model was obtained by backward 
stepwise elimination of the nonsignificant factors, each 
of the excluded variables was again entered separately 
into the model to test its contribution to the final model. 
The results are given as odds ratio (OR) estimates of 
relative risk, with the 95% CI. The Hosmer-Lemeshow 
goodness-of-fit chi-square test was used to assess the 
calibration of each model. This test compares the 
expected and observed distribution of cases and controls 
across deciles of predicted risk. Therefore, for this test, 
a higher probability value corresponds to a model with 
a better fit.
Statistical analysis was performed using the computer 
software SPSS (version 12.9 for Windows, SPSS, 
Chicago, Illinois, USA) and Medcalc (version 6.0 for 
Windows,). Statistical significance was established at the 
P<0.05 level.
RESULTS
1. Predictor and outcome characteristics
The patient characteristics of the predictor variables 
are listed in Table 1. With regard to the stroke mecha-
nism, 253 patients (58%) were classified with athero-
sclerotic stroke, 97 (22%) with cardioembolic stroke, 67 
(15%) with cryptogenic stroke, and 20 (5%) with other 
determined etiology. Systemic causes of aggravation 
were present in 59 patients (13.5%).
The baseline NIHSS scores are shown in Fig. 2. 
About 60% and 10% of the patients had scores of ≤5 
and >13, respectively. There was a significant corre-
lation between the DWI lesion volume and the baseline 
NIHSS score (r=0.588, P<0.001) (Fig. 2-B). The NIHSS 
score tended to decrease during the first 7 days of 
admission, although this was not statistically significant: 
5.56±5.27 at baseline, 5.17±5.17 at day 1, 4.77±5.41 
at day 3, and 4.38±5.64 at day 7. Moreover, marked 
changes (≥4) in the NIHSS score were observed during 
this period, reflecting improvement in 59 patients 
(13.5%) and worsening in 24 patients (5.5%).
The patient outcomes are listed in Table 2. More than 
50% of the patients showed excellent outcome, whereas 
about 25% showed poor outcome and 24 patients (5.5%) 
died.
2. Optimal time points and threshold for different 
endpointsJournal of Clinical Neurology: Vol. 1, No. 1, 2005
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A   B
Figure 2. (A) Frequency distribution of baseline NIHSS scores in the study population. (B) Infarct volume as measured by DWI for 
each baseline NIHSS score in the study population.
Outcome variable 7 days 3 month 6 months
BI
≥95 
60 to <95
<60 
210 (50.4%)
78 (18.7%)
129 (30.9%)
234 (53.5%)
95 (21.7%)
108 (24.7%)
254 (58.1%)
 81 (18.5%)
102 (23.3%)
Modified Rankin scale score
0 or 1 
2 or 3 
4 or 5 
188 (45.0%)
113 (27.0%)
117 (28.0%)
209 (47.8%)
131 (30.0%)
 79 (18.1%)
237 (54.2%)
111 (25.4%)
 65 (14.9%)
Global endpoint
Poor outcome
Excellent outcome
133 (30.4%)
174 (39.8%)
110 (25.2%)
199 (45.6%)
108 (24.7%)
238 (54.5%)
Death -  18 (4.1%)  24 (5.5%)
Table 2. Outcome-variable characteristics
The area under the ROC curve for each NIHSS score 
is listed in Table 3, and the ROC curves for a poor 
outcome are shown in Fig. 3. The area under the ROC 
curve varied between 0.89 and 0.94 (with 0.5 indicating 
no discrimination and 1 indicating perfect discrimi-
nation). The discrimination was better for the NIHSS 
score determined 7 days after admission than for earlier 
NIHSS scores; the areas under the ROC curve for poor 
outcome were 0.887, 0.927, 0.938, and 0.908 for the 
baseline, 3rd-, 7th-, and 14th-day NIHSS scores, 
respectively. Statistical comparisons suggested that the 
NIHSS score taken 7 days after admission had a better 
predictive performance than did the baseline NIHSS 
score (P=0.003, difference=0.054), whereas the area 
under the ROC curve did not differ significantly 
between the 7th- and 14th-day NIHSS scores (P=0.610, Bang OY, et al. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory  
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Outcome at 6 months:
Area under the ROC curve (95% CI)
Poor prognosis Excellent prognosis
Baseline NIHSS score
3rd-day NIHSS score
7th-day NIHSS score
14th-day NIHSS score
0.887 (0.853-0.915)
0.927 (0.898-0.950)
0.938 (0.911-0.959)
0.908 (0.854-0.946)
0.872 (0.837-0.902)
0.894 (0.861-0.922)
0.898 (0.866-0.925)
0.927 (0.878-0.961)
Table 3. Areas under the ROC curves
Figure 3. Comparisons of the ROC curve between (A) baseline and 7th-day NIHSS scores, and (B) 7th- and 14th-day NIHSS scores.
difference=0.006) (Fig. 3). For an excellent prognosis, 
there was no significant difference between the baseline 
and 7th-day NIHSS scores (P=0.104, difference=0.025) 
or between the 7th- and 14th-day NIHSS scores (P= 
0.464, difference=0.007).
The NIHSS score strongly predicted the likelihood of 
patient recovery after stroke. An NIHSS score of ≥6 at 
7 days after admission predicted a poor outcome with a 
sensitivity of 84% (95% CI, 76-90%), a specificity of 
92% (95% CI, 88-94%), and positive and negative 
predictive values of 77% and 95%, respectively. The 
best predictor for an excellent prognosis at 7 days was 
an NIHSS score of ≤3, which gave a sensitivity of 91% 
(95% CI, 87-94%), a specificity of 75% (95% CI, 
68-81%), and positive and negative predictive values of 
81% and 87%, respectively.
3. Prognostic models for long-term outcomes
Table 4 lists the OR and CI values for the factors in 
the multiple logistic regression model. The significant 
factors in the model were similar between the two 
prognostic endpoints. Age, DWI lesion volume, and the 
NIHSS score at 7 days after admission were indepen-
dently associated with both prognostic endpoints, with 
the last being the strongest predictor. Stroke history was 
an independent predictor for poor outcome - but not for 
excellent outcome - at 6 months after symptom onset. 
Patients with an NIHSS score of ≥6 at 7 days after 
admission were about 52 times more likely to remain in 
a severely disabled state at 6 months after stroke than 
were patients with an NIHSS score of <6, after adjusting Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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Variable 
Poor outcome Excellent outcome
OR (95% CI) P OR (95% CI) P
Age, per 1-year increase
Stroke history
DWI lesion volume, per 1-ml increase
NIHSS score at day 7
≥6 
≤3
1.15 (1.04-1.27)
11.24 (1.25-100.96)
1.03 (1.01-1.15)
51.97 (6.57-411.37)
-
0.005
0.031
0.012
<0.001
-
0.90 (0.90-0.99)
N/A
0.98 (0.96-0.99)
-
17.427 (5.291-57.40)
0.018
0.321
0.038
-
<0.001
Table 4. Multiple logistic regression test
Reference
No. of 
patients
Enrollment and endpoint Factors analyzed Predictor models
Adams HP, et al.
12 1,281 Any stroke within 24 hours 
Global endpoint at 3 months
Baseline NIHSS score, age/sex, 
stroke subtype, stroke history 
Baseline NIHSS score, lacunar 
stroke, age, sex, race, previous 
stroke
Counsell C, et al.
19  530 Any first-ever stroke within 30 
days 
Survival at 30 days and inde-
pendent state at 6 months 
Age/sex, social status, prestroke 
disability, risk factors, Glasgow 
Coma Scale score, neurological 
deficits, laboratory results
Six simple variables (age, living 
alone, independence in ADL 
before stroke, verbal component 
of Glasgow Coma Scale, arm 
power, ability to walk)
Muir KW, et al.
4 373 Any acute stroke
Alive at home or in care, or 
dead at 3 months
Baseline NIHSS score, Guy's 
prognostic score, The Canadian 
Neurological Scale score, MCA 
Neurological Score
Baseline NIHSS score best 
predicts 3-month outcome. No 
other score added useful 
information to the NIHSS 
score. (All patients with 
baseline NIHSS score of (13 
had poor outcome)
Tilling K, et al.
20 299 Any stroke
BI at 1 year
Age/sex, neurological deficits  Urinary incontinence, sex, 
prestroke disability, dysarthria
Weimar C, et al.
6 1,023 Any stroke within 6 hours of 
onset
BI at 100 days
Age/sex, stroke history, baseline 
NIHSS score, atrial fibrillation
Age, baseline NIHSS score
Baird AE, et al.
21 66 Any acute stroke within 48 
hours of onset
BI at 1 to 3 months
Age/sex, history of hypertension 
or heart disease, NIHSS score, 
entry into drug trial, time from 
onset of symptoms to magnetic 
resonance imaging, DWI lesion 
volume
Combined measurements of the 
NIHSS score, time in hours 
from stroke onset to DWI, 
volume of ischemic brain tissue 
on DWI gave the best 
prediction of stroke recovery
This study 437 Nonlacunar stroke in MCA 
territory within 72 hours
Global endpoints at 6 months
Several additional factors, 
including the DWI lesion volume, 
vascular status, inflammatory 
markers, metabolic syndrome 
markers, systemic causes of 
deterioration
NIHSS score at day 7, age, 
previous stroke, DWI lesion 
volume
Table 5. Differences between  predictor modelsBang OY, et al. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory  
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Figure 4. Comparisons of the ROC curve between the NIHSS criteria and the models for (A) a poor prognosis and (B) an excellent
prognosis.
for other factors. Similarly, patients with an NIHSS 
score of ≤3 at 7 days after admission were about 17 
times more likely to regain independent life, after 
adjusting for other factors. The multilevel model was 
internally valid, as shown by the good fit of the model 
on the study population for a poor prognosis (χ
2= 
10.497, df=8, P=0.232) and an excellent prognosis (χ
2 
= 10.497, df=8, P=0.232).
To develop prognostic models for long-term outcome, 
point values were assigned to each factor by multiplying 
the β  coefficients from the logistic regression model by 
33 for a poor prognosis and 50 for an excellent 
prognosis, and rounding off to the nearest integer. The 
resulting point values assigned to each factor used in 
calculating the poor-prognosis risk index were (a) 1 
point for each milliliter infarct volume, (b) 4.7 points for 
each year of age, (c) 80 points for the presence of 
previous stroke, and (d) 130 points for the presence of 
severe deficits at 7 days after admission, defined as an 
NIHSS score of ≥6. Similarly, the points for an 
excellent-prognosis risk index were (a) -1 point for each 
milliliter of infarct volume, (b) -2.8 points for each year 
of age, and (c) 143 points for the presence of mild 
deficits at 7 days after admission, defined as an NIHSS 
score of ≤3.
The ROC curves for the NIHSS criteria and the 
models for poor and excellent prognoses are shown in 
Fig. 4. We measured the areas under the ROC curves for 
poor and excellent prognoses using the NIHSS criteria 
and using a model that included age, DWI lesion 
volume, and stroke history. For a poor prognosis at 6 
months after stroke, the area under the ROC curve was 
0.878 (95% CI, 0.842-0.907) using only the NIHSS 
criteria (score of ≥6 at 7 days after admission), and 
increased to 0.919 (95% CI, 0.888-0.943) using the 
prognostic model that included age, DWI lesion volume, 
and stroke history. However, statistical comparisons 
indicated that the area under the ROC curve did not 
differ significantly between the NIHSS criteria and the 
prognostic model (P=0.079, difference=0.041). Discrimi-
nating an excellent prognosis was better for the 
prognostic model than for the NIHSS criteria (score of 
≤3 at 7 days after admission). The areas under the 
ROC curves for an excellent outcome were significantly 
higher for the combined prognostic model than for the 
NIHSS criteria (0.876 vs 0.825, respectively; P=0.004).
DISCUSSION
Our study is unique in that (a) our patients represented 
a homogeneous group (those with nonlacunar stroke 
within the MCA territory) due to our exclusion of 
patients with lacunar stroke and posterior circulation Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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stroke, and (b) DWI data were analyzed. Most previous 
studies analyzed stroke of several etiologies and 
considered different factors (Table 5).
4,6,12,19-21 Patients 
with lacunar stroke are known to have an excellent 
long-term prognosis regardless of their baseline clinical 
characteristics,
12 and are therefore not suitable candidates 
for most acute- or subacute-stroke trials. For patients 
with posterior circulation stroke, it has been reported 
that there is no significant correlation between the 
infarct size as measured by the DWI volume and the 
NIHSS score.
22 Indeed, we found that the predictive 
performance of the serial NIHSS scores was worse in 
187 patients with posterior circulation stroke (data not 
shown) than in the patients with MCA territory infarcts 
reported here.
The accurate prediction of outcome in the acute and 
subacute phases of stroke would be of value in both 
epidemiological research and clinical practice.
19 Although 
there have been numerous investigations of prognostic 
models to predict long-term stroke outcome, most of 
these have focused on patients in the hyperacute stage of 
stroke. The present study has yielded a prognostic model 
for patients with subacute stroke that may guide patient 
management in clinical practice or patient enrollment in 
clinical trials. Our results of prognostic factors in 
subacute stroke were different from those in acute-stroke 
trials. The model for acute-stroke trials could not be 
used in the subacute-stroke trial for several reasons. The 
results of the present study show that the major 
prognostic factors at the subacute stage of stroke were 
ischemic injury (DWI lesion volume), the ability to 
recover functional level (patient age), or both (NIHSS 
score at the subacute stage). In an acute-stroke trial, 
stroke outcome can be greatly influenced by numerous 
factors, such as recanalization, evolving stroke, reper-
fusion injury, and collateral circulation. However, the 
influence of these factors on stroke outcome would be 
lower in a subacute-stroke trial than in an acute-stroke 
trial. Our logistic regression analysis of prognostic 
factors at 7 days after admission in the present study 
showed that systemic factors of aggravation (e.g., initial 
hyperglycemia or hyperpyremia) and degree of stenosis 
were not independent predictors of long-term outcome. 
Our results are consistent with those of a previous study 
in which a significant number of patients with acute 
ischemic stroke treated with conventional therapy 
showed early improvement or worsening, as assessed by 
the NIHSS score.
23 These results indicate that the 
NIHSS scores at a more optimal time point - relative to 
baseline - should be used in evaluations for subacute- 
stroke trials.
In the present study, the NIHSS score at 7 days after 
admission was the best at predicting the 6-month 
outcome. Patients with severe neurological deficits after 
acute ischemic stroke, as quantified by the NIHSS, have 
poor prognoses. We found the discriminatory power in 
predicting stroke outcome was higher for the NIHSS 
score taken at 7 days after admission than for the 
baseline NIHSS score, suggesting that early changes in 
stroke scores influence outcome predictions. After the 
1st week following admission, it is possible to identify 
a subset of patients who are highly likely to experience 
a poor outcome. Our later NIHSS score (i.e., that at day 
14) did not provide useful additional information in this 
study. It has been shown that the clinical course of 
recovery stabilizes beyond day 4, with improvement 
occurring linearly over time from then on.
24 Cutoff 
NIHSS scores of 6 and 3 were the best at predicting a 
poor prognosis and an excellent prognosis at 6 months 
after stroke, respectively.
Our results have important implications for the choice 
of patients enrolled in subacute-stroke trials. Spontaneous 
recovery occurs frequently in patients with a good 
prognosis after stroke. Conversely, patients with very 
severe stroke may be destined for a poor outcome, 
regardless of any intervention.
25 The NIHSS score can 
be used as an exclusion or inclusion criterion for the 
enrollment of patients in trials testing new treatments for 
stroke, as follows. For subacute-stroke trials that may be 
harmful, patient enrollment should be restricted to those 
with an NIHSS score of ≥6 at 7 days after admission; 
enrollment in a trial that presents significant risk should 
require an even higher score. Similarly, patients with an 
NIHSS score of ≤3 should not be included in stroke 
trials, even if the treatment modality is not extensive or 
hazardous. The recruitment of patients with low NIHSS 
scores into a trial designed to test a promising inter-
vention would likely obscure any treatment effect and Bang OY, et al. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory  
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thus could increase the likelihood of rejecting a 
potentially beneficial therapy.
In addition to the NIHSS score after stroke, differences 
in baseline patient characteristics can also influence 
study group outcomes. In previous studies, several 
clinical characteristics have been shown to influence the 
final clinical status: for example, age,
26 stroke severity,
12 
and stroke subtype
27 each influence the mortality rate. 
Our logistic regression analysis revealed that age, 
presence of previous stroke, DWI lesion volume, and 
NIHSS score at 7 days after admission were independent 
predictors of the long-term outcome. Our results are in 
agreement with those of other studies performed 
hyperacute-stroke settings.
21 However, we have also 
shown that no factor used in addition to the 7th-day 
NIHSS score improved the prediction of a poor 
long-term outcome. For excellent prognosis, the discrimi-
nation was marginally better with the prognostic model 
that included the other factors than with the NIHSS 
criteria alone.
This study has several limitations. Our population was 
a hospital-based cohort, and unselected patients in 
different care settings might have prognoses that differ 
from those suggested in our models. In other words, our 
results can only be considered valid for patients in 
Korean acute-stroke units and cannot be automatically 
extrapolated to stroke registers or other stroke-care 
institutions. Although the stroke history was analyzed in 
our study, prestroke disability was not considered. 
Several studies have shown that prestroke disability 
affects the level of outcome after stroke,
19,20 and hence 
further studies involving patients with first-time strokes 
are needed.
In summary, our study shows that the NIHSS score at 
7 days after admission provides a clinically useful 
discrimination point for accurate forecasting of long- 
term outcomes after stroke. We issue a caution that 
randomization into clinical trials without stratification of 
stroke severity increases the risk of testing two patient 
populations with different clinical courses. Our data may 
be helpful in predicting long-term prognosis as well as 
in decision-making concerning novel therapeutic appli-
cations in the subacute stage after stroke.
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